CAS Investment/Sosin Disclose 5.2M CDLX Shares (~9.8%) and Convertible Notes
Rhea-AI Filing Summary
CAS Investment Partners, Sosin Master and related entities report combined shared beneficial ownership of 5,198,067 shares of Cardlytics (CDLX), representing approximately 9.8% of the outstanding common stock based on 53,236,901 shares outstanding as of July 31, 2025. Sosin Master directly holds 3,198,584 shares (about 6.0%) and CSWR directly holds 1,999,483 shares (about 3.8%). The filing states the Sosin entities purchased shares in open market transactions funded primarily with working capital; aggregate purchase prices were approximately $88.6 million for Sosin Master and $65.0 million for CSWR. Reporting persons disclose shared voting and dispositive power only and note holdings of convertible notes with principal amounts of $13.74 million (Sosin Master) and $7.50 million (CSWR), which may be settled in cash or shares at the issuer’s option.
Positive
- Combined stake of 5,198,067 shares representing approximately 9.8% of CDLX outstanding is a material ownership position
- Sosin Master directly owns 3,198,584 shares (~6.0%) and CSWR directly owns 1,999,483 shares (~3.8%)
- Aggregate purchase prices disclosed: approximately $88.62 million for Sosin Master and $65.03 million for CSWR, showing clear capital commitment
Negative
- No sole voting or dispositive power reported — all voting and disposition is shared, indicating no unilateral control
- Convertible notes held are not treated as beneficially owned because the issuer may settle conversions in cash, shares, or a combination, creating contingent exposure
Insights
TL;DR: Combined ownership of ~9.8% of CDLX via open-market purchases funded with working capital; holdings include convertible notes.
The disclosed positions are material in size relative to the 53.24 million shares outstanding, with Sosin Master holding ~6.0% and CSWR ~3.8%. The filing documents aggregate cash outlays of approximately $153.6 million across the two funds, indicating meaningful capital commitment. The reporting parties assert only shared voting and dispositive power, not sole control. The convertible notes positions create potential future equity exposure but are not treated as beneficially owned due to issuer conversion settlement discretion.
TL;DR: A near-10% shared stake is significant for governance dynamics, though no sole voting control is claimed.
The disclosure signals an influential minority ownership block that could affect shareholder votes or negotiations, yet the reporting persons explicitly report no sole voting or dispositive power. That distinction limits immediate unilateral control but preserves the potential for coordinated action among related entities. The pro rata distributions and recent open-market activity are documented, and the presence of notes convertible at the issuer’s option warrants attention as potential dilutive exposure depending on future settlement choices.
FAQ
How many Cardlytics (CDLX) shares do the Sosin entities report owning?
What are the individual holdings of Sosin Master and CSWR in CDLX?
How were the purchases funded according to the filing?
What cash amounts did the reporting persons pay to acquire their CDLX positions?
Do the reporting persons have sole voting or dispositive power over these shares?
Are there convertible notes mentioned in the filing and who holds them?